SUPN
USDSupernus Pharmaceuticals Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$55.430
High
$57.400
Low
$54.610
Volume
4.00M
Company Fundamentals
Market Cap
3.2B
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Trading Stats
Avg Volume
0.82M
Exchange
NGM
Currency
USD
52-Week Range
Related News
B of A Securities Initiates Coverage On Supernus Pharmaceuticals with Buy Rating, Announces Price Target of $65
B of A Securities analyst Pavan Patel initiates coverage on Supernus Pharmaceuticals with a Buy rating and announces Price Target of $65.
TD Cowen Maintains Buy on Supernus Pharmaceuticals, Raises Price Target to $60
TD Cowen analyst Stacy Ku maintains Supernus Pharmaceuticals with a Buy and raises the price target from $45 to $60.
Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
ROCKVILLE, Md., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system
Piper Sandler Upgrades Supernus Pharmaceuticals to Overweight, Raises Price Target to $65
Piper Sandler analyst David Amsellem upgrades Supernus Pharmaceuticals from Neutral to Overweight and raises the price target from $40 to $65.
Related Stocks
RILYZ
B. Riley Financial Inc. 5.25% Senior Notes due 2028
COKE
Coca-Cola Consolidated Inc.
DJTWW
Trump Media & Technology Group Corp. Warrants
TCRX
TScan Therapeutics Inc.
CEP
Cantor Equity Partners Inc. Ordinary Shares
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.